News about Hepatic cancer

Analysing the potential of AI for classifying liver lesions in magnetic resonance imaging reports

A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magnet1

Clínic Barcelona

Research September 19 2024

Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1

Clínic Barcelona

Research June 14 2023

Researchers at the Hospital Clínic-IDIBAPS participate in the new guidelines on intrahepatic cholangiocarcinoma

Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the secon1

Clínic Barcelona

Research October 4 2022

Researchers describe a genetic signature that predicts the response to immunotherapy treatment in liver cancer

In an important breakthrough in precision medicine and for the approval of cost-effective treatments, the expression of eleven genes is found to make1

Clínic Barcelona

Research May 31 2022

How have treatments for hepatocellular carcinoma improved?

Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1

News about Hepatic cancer

Analysing the potential of AI for classifying liver lesions in magnetic resonance imaging reports

Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

Researchers at the Hospital Clínic-IDIBAPS participate in the new guidelines on intrahepatic cholangiocarcinoma

Researchers describe a genetic signature that predicts the response to immunotherapy treatment in liver cancer

How have treatments for hepatocellular carcinoma improved?

Subscribe to the Newsletter of Clínic